T S Scanlan1, H A Yoshihara, N H Nguyen
1Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, University of California-San Francisco, San Francisco, CA 94143-0446, USA. scanlan@cgl.ucsf.edu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Developing selective thyromimetics offers a promising approach to target tissue-specific thyroid hormone actions. These compounds can help treat metabolic disorders by selectively modulating thyroid hormone receptor pathways.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: